NCT06258057View on ClinicalTrials.gov

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

Active, not recruitingOBSERVATIONAL
Enrollment

365,000

Participants

Timeline

Start Date

January 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pertussis (Whooping Cough)
Interventions
OTHER

Not applicable / database analysis

Not applicable / database analysis

Trial Locations (1)

91380

Investigational Site, Chilly-Mazarin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT06258057 - Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy | Biotech Hunter | Biotech Hunter